In contrast, our cohort of patients who had strictly compensated ACLD of majorly viral etiology with mostly subclinical portal hypertension showed virtually no alternative RAS activity in their plasma, with Ang 1–7 being undetectable in 92.3% of patients in this cohort. Here, ANGPT1 is linked to portal hypertension.